Skip to content

Clinical trials

Terminated Lymphoma, Large B-Cell, Diffuse trials in South Korea

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Lymphoma, Large B-Cell, Diffuse Status: Terminated Country / region: South Korea Clear all

13 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20061
20112
20121
20151
20162
20171
20211
20221
20233

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Terminated13

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Genmab2
Hoffmann-La Roche2
Novartis Pharmaceuticals2
Pfizer2
ADC Therapeutics S.A.1
Celltrion1
Janssen Research & Development, LLC1
Spectrum Pharmaceuticals, Inc1
TG Therapeutics, Inc.1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Lymphoma, Large B-Cell, Diffuse13
Lymphoma, Follicular4
Lymphoma, Mantle-Cell3
Lymphoma2
Lymphoma, B-Cell, Marginal Zone2
Lymphoma, Non-Hodgkin2
Recurrence2
Leukemia, Lymphocytic, Chronic, B-Cell1
Leukemia, Myeloid, Acute1
Multiple Myeloma1

Trials

Showing 1 to 13 of 13. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.